Doximity Stock Intrinsic Value – Needham Downgrades Doximity Stock to a ‘Hold’
December 16, 2023

🌥️Trending News
Needham has recently downgraded Doximity ($NYSE:DOCS) Inc’s stock to a ‘Hold’ rating. Doximity Inc is a healthcare technology company based in San Francisco, California. Needham’s decision to downgrade Doximity Inc’s stock to a ‘Hold’ rating reflects the challenges that the company may face in the future. Though the company has seen steady growth since its inception, Needham believes that any further growth may be hindered by competition from other companies in the healthcare technology industry.
Additionally, Needham believes that the company may experience difficulty in gaining users due to the sensitive nature of medical information and its associated privacy laws. Though Needham has downgraded Doximity Inc’s stock to a ‘Hold’ rating, they still remain optimistic about the company’s potential for growth. Needham recognizes the company’s strong presence in the healthcare technology industry and believes that Doximity Inc can maintain its position as a leader if it continues to innovate and find ways to differentiate itself from its competitors.
Price History
Following the downgrade, DOXIMITY stock opened at $25.2 and closed at $26.5, resulting in a 7.5% rise from the previous closing price of $24.7. Analysts cited continued outperformance of the stock and overextension of the valuation as reasons for the downgrade. Despite the downgrade, some investors remain optimistic about the company’s future prospects and have continued to trade DOXIMITY stock. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Doximity. More…
| Total Revenues | Net Income | Net Margin |
| 448.31 | 123.14 | 28.9% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Doximity. More…
| Operations | Investing | Financing |
| 165.43 | 67.32 | -198.03 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Doximity. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 1.03k | 154.1 | 4.62 |
Key Ratios Snapshot
Some of the financial key ratios for Doximity are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 53.3% | 78.1% | 31.8% |
| FCF Margin | ROE | ROA |
| 35.8% | 9.6% | 8.7% |
Analysis – Doximity Stock Intrinsic Value
GoodWhale has conducted a thorough analysis of DOXIMITY‘s fundamentals. After rigorous calculations, we have determined that the intrinsic value of DOXIMITY share is around $51.5. This figure was calculated using our proprietary Valuation Line, which takes into account a range of financial and market data. Currently, DOXIMITY stock is trading at $26.5, meaning it is significantly undervalued by 48.5%. We believe that this discrepancy represents a great opportunity for investors to capitalize on a potentially lucrative market. We recommend that investors act quickly and take advantage of this opportunity while it still exists. More…

Peers
In the medical field, there is intense competition between Doximity Inc and its competitors MEDLEY Inc, Welby Inc, and Topchoice Medical Corp. All four companies are vying for the top spot in the industry, and each has its own unique strengths and weaknesses. Doximity Inc has a strong focus on technology and innovation, while MEDLEY Inc has a more traditional approach to medicine. Welby Inc is known for its high-quality customer service, and Topchoice Medical Corp has a wide range of products and services.
– MEDLEY Inc ($TSE:4480)
MEDLEY Inc. is a publicly traded company with a market capitalization of $103.2 billion as of 2022. The company has a return on equity of 5.77%. MEDLEY Inc. is a leading provider of healthcare services in the United States. The company’s services include medical and dental care, mental health services, and prescription drug coverage.
– Welby Inc ($TSE:4438)
Welby Inc is a publicly traded company with a market capitalization of $3.66 billion as of 2022. The company has a return on equity of 0.13%. Welby Inc is a diversified holding company with operations in a variety of industries, including healthcare, automotive, industrial, and consumer products. The company’s healthcare businesses include a provider of home health and hospice services, a provider of senior living services, and a provider of healthcare services to the government. The company’s automotive businesses include a provider of automotive parts and services, a provider of vehicle financing, and a provider of automotive aftermarket products and services. The company’s industrial businesses include a provider of industrial products and services, a provider of energy services, and a provider of logistics and transportation services. The company’s consumer products businesses include a provider of home improvement products and services, a provider of home furnishings, and a provider of consumer electronics.
– Topchoice Medical Corp ($SHSE:600763)
Topchoice Medical Corp is a publicly traded company that focuses on providing medical services. The company has a market capitalization of 44 billion as of 2022 and a return on equity of 19.02%. Topchoice has been in business for over 10 years and is headquartered in the United States. The company operates in over 60 countries and provides medical services to millions of patients each year. Topchoice is a publicly traded company and its shares are listed on the NASDAQ stock exchange.
Summary
Doximity Inc. is a healthcare technology company that has been experiencing stock price growth. Despite this positive outlook, Needham recently downgraded the stock to a Hold, citing a lack of clarity regarding the company’s earnings outlook. This downgrade has not appeared to impact investor confidence, however, as the stock price moved up the same day. Analysts suggest that investors should be cautious of the company’s outlook, as further downside risks may exist.
Investors should consider additional factors such as the company’s competitive position and financial position before making any investment decision. Ultimately, investors should conduct their own due diligence before making any investment decisions.
Recent Posts









